Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

13.07
-0.3800-2.83%
Post-market: 13.200.1300+0.99%19:32 EDT
Volume:1.30M
Turnover:17.12M
Market Cap:1.23B
PE:-4.14
High:13.83
Open:13.69
Low:12.80
Close:13.45
52wk High:16.33
52wk Low:1.50
Shares:94.22M
Float Shares:77.49M
Volume Ratio:0.48
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1550
EPS(LYR):-3.3828
ROE:-134.29%
ROA:-51.30%
PB:11.66
PE(LYR):-3.86

Loading ...

Replimune Group put volume heavy and directionally bearish

TIPRANKS
·
Jun 29

Replimune Group Q4 EPS $(0.76) Misses $(0.71) Estimate

Benzinga Earnings
·
Jun 29

Replimune Group Inc Reports Results for the Quarter Ended March 31 - Earnings Summary

Reuters
·
Jun 29

Replimune's Fiscal Q4 Net Loss Narrows

MT Newswires Live
·
Jun 29

Earnings Flash (REPL) Replimune Posts Fiscal 2026 Net Loss $3.38 a Share, vs. FactSet Est of $3.27 Loss

MT Newswires Live
·
Jun 29

Replimune FY26 Net Loss Widens to $313.94 Million; R&D Expenses Rise to $221.18 Million

Reuters
·
Jun 29

Replimune Reports Fiscal Fourth Quarter and Year End 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Jun 29

Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL) and Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Jun 29

Replimune Group Inc : JP Morgan Raises to Overweight from Neutral; Raises Target Price to $17 from $8

THOMSON REUTERS
·
Jun 26

Replimune Slips as FDA Accepts Skin Cancer Drug Review, but Advisory Panel Adds Risk

Reuters
·
Jun 26

Replimune Says FDA Accepts RP1 Melanoma BLA Resubmission for Review

Reuters
·
Jun 26

Replimune Group - FDA Sets August 2, 2026 Goal Date for Rp1 Bla Review

THOMSON REUTERS
·
Jun 26

Replimune Announces FDA Acceptance of Rp1 Biologics License Application Resubmission for Advanced Melanoma

THOMSON REUTERS
·
Jun 26

U.S. Earnings Preview: Before Market Open June 25

Dow Jones
·
Jun 25

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

InvestorPlace
·
Jun 19

Replimune Group Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
Jun 19

U.S. Earnings Preview: Before Market Open June 18

Dow Jones
·
Jun 18

U.S. Earnings Preview: Before Market Open June 11

Dow Jones
·
Jun 11

U.S. Earnings Preview: Before Market Open June 4

Dow Jones
·
Jun 04

Replimune Chief Commercial Officer Christopher Sarchi sells 12,000 shares for $110,880

Reuters
·
Jun 04